Supplemental Annuity Collective Trust (SACT) of New Jersey’s Nektar Therapeutics NKTR Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-667	Closed	-$5.75K	–	216
2023 Q2	$5.75K	Hold	667	–	–	﹤0.01%	219
2023 Q1	$7.03K	Hold	667	–	–	﹤0.01%	217
2022 Q4	$22.6K	Hold	667	–	–	0.01%	214
2022 Q3	$32K	Hold	667	–	–	0.01%	212
2022 Q2	$38K	Hold	667	–	–	0.02%	218
2022 Q1	$54K	Hold	667	–	–	0.02%	223
2021 Q4	$135K	Hold	667	–	–	0.04%	221
2021 Q3	$180K	Hold	667	–	–	0.06%	219
2021 Q2	$172K	Hold	667	–	–	0.06%	220
2021 Q1	$200K	Hold	667	–	–	0.07%	215
2020 Q4	$170K	Hold	667	–	–	0.06%	210
2020 Q3	$166K	Hold	667	–	–	0.07%	205
2020 Q2	$232K	Sell	667 -133	-17%	-$41.5K	0.11%	193
2020 Q1	$214K	Hold	800	–	–	0.12%	182
2019 Q4	$259K	Hold	800	–	–	0.11%	200
2019 Q3	$219K	Hold	800	–	–	0.1%	205
2019 Q2	$427K	Hold	800	–	–	0.19%	169
2019 Q1	$403K	Hold	800	–	–	0.18%	177
2018 Q4	$394K	Buy	+800	New	+$483K	0.2%	157

Other funds holding NKTR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's NKTR Position: Q3 2023 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey sold out of Nektar Therapeutics (NKTR) in Q3 2023, closing a stake of 667 shares — an estimated $5.75K sold.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in NKTR in Q4 2018 and held it in 19 quarters. The position peaked at $427K in Q2 2019. 138 funds tracked by Wall St. Rank hold NKTR as of Q3 2023.

Supplemental Annuity Collective Trust (SACT) of New Jersey reported no remaining Nektar Therapeutics position as of Q3 2023 after selling out during the quarter.
Supplemental Annuity Collective Trust (SACT) of New Jersey sold 667 Nektar Therapeutics shares in Q3 2023, an estimated $5.75K.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Nektar Therapeutics in Q4 2018 and held it in 19 quarters.
Supplemental Annuity Collective Trust (SACT) of New Jersey's Nektar Therapeutics position peaked at $427K in Q2 2019.
138 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2023.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q3 2023, filed 8 Nov 2023.